Stoke Therapeutics Inc
STOK - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$1.75B
Close$
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $1.75 Billion |
|---|---|
| Enterprise Value | $1.64 Billion |
| Earnings per Share | $-0.12 |
| Beta | 1.38 |
| Outstanding Shares | 68,362,880 |
Return
| Return on Equity | -68.98% |
|---|---|
| Return on Assets | -59.80% |
| Return on Invested Capital | -70.99% |
Valuation & Multiples
| P/E Ratio | -7.04 |
|---|---|
| PEG | -7.65 |
| Price to Sales | - |
| Price to Book Ratio | 5.34 |
| Enterprise Value to Revenue | 58.28 |
| Enterprise Value to EBIT | -6.47 |
| Enterprise Value to Net Income | -7 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.02 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
-$0.93
Consensus analyst estimateRevenue Estimate
$8.21 M
Consensus analyst estimateNext Earnings Call
Expected Date
March 15, 2027
EPS Estimate
-$1.15
Consensus analyst estimateRevenue Estimate
$8.04 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 137.78% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.39%▼ 114.26% |
|---|---|
| Total Invested | $126.95M▼ 94.94% |
| Investors Holding | 56▼ 147.00% |
About Stoke Therapeutics Inc
CEO: Edward Kaye
